Prevalence of lipid abnormalities before and after introduction of lipid modifying therapy among Swedish patients with dyslipidemia (PRIMULA)
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2458
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Prevalence of lipid abnormalities before and after introduction of lipid modifying therapy among Swedish patients with dyslipidemia (PRIMULA) ; volume:10 ; number:1 ; day:29 ; month:11 ; year:2010 ; pages:1-10 ; date:12.2010
BMC public health ; 10, Heft 1 (29.11.2010), 1-10, 12.2010
- Urheber
-
Pettersson, Billie
- Beteiligte Personen und Organisationen
-
Ambegaonkar, Baishali
Sazonov, Vasilisa
Martinell, Mats
Stålhammar, Jan
Wändell, Per
SpringerLink (Online service)
- DOI
-
10.1186/1471-2458-10-737
- URN
-
urn:nbn:de:1111-2016081336134
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:57 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Pettersson, Billie
- Ambegaonkar, Baishali
- Sazonov, Vasilisa
- Martinell, Mats
- Stålhammar, Jan
- Wändell, Per
- SpringerLink (Online service)
Ähnliche Objekte (12)
Evolving targets for lipid‐modifying therapy
Dyslipidemia, lipid-lowering agents and neuroendocrine neoplasms: new horizons
Management of Lipid Abnormalities in Patients with Diabetes
Lipid profile and dyslipidemia among school-age children in urban Ghana
Deficiency of the lipid flippase ATP10A causes diet-induced dyslipidemia in female mice
Modeling the risk factors for dyslipidemia and blood lipid indices: Ravansar cohort study
Lipid and polymer lipid systems
Lipids, lipid-modifying drug target genes and migraine: a Mendelian randomization study
Lipid protein interactions in lipid membranes
Lipid pigments
Lipid and immune abnormalities causing age-dependent neurodegeneration and Parkinson’s disease
Glucose and Lipid Metabolism Abnormalities among Patients with Autosomal Dominant Polycystic Kidney Disease
Evolving targets for lipid‐modifying therapy
Dyslipidemia, lipid-lowering agents and neuroendocrine neoplasms: new horizons
Management of Lipid Abnormalities in Patients with Diabetes
Lipid profile and dyslipidemia among school-age children in urban Ghana
Deficiency of the lipid flippase ATP10A causes diet-induced dyslipidemia in female mice
Modeling the risk factors for dyslipidemia and blood lipid indices: Ravansar cohort study
Lipid and polymer lipid systems
Lipids, lipid-modifying drug target genes and migraine: a Mendelian randomization study
Lipid protein interactions in lipid membranes
Lipid pigments
Lipid and immune abnormalities causing age-dependent neurodegeneration and Parkinson’s disease
Glucose and Lipid Metabolism Abnormalities among Patients with Autosomal Dominant Polycystic Kidney Disease
Evolving targets for lipid‐modifying therapy
Dyslipidemia, lipid-lowering agents and neuroendocrine neoplasms: new horizons
Management of Lipid Abnormalities in Patients with Diabetes
Lipid profile and dyslipidemia among school-age children in urban Ghana
Deficiency of the lipid flippase ATP10A causes diet-induced dyslipidemia in female mice
Modeling the risk factors for dyslipidemia and blood lipid indices: Ravansar cohort study
Lipid and polymer lipid systems
Lipids, lipid-modifying drug target genes and migraine: a Mendelian randomization study
Lipid protein interactions in lipid membranes
Lipid pigments
Lipid and immune abnormalities causing age-dependent neurodegeneration and Parkinson’s disease